Resources

Resource types
  • Resource types

  • Resource types

Novel solution - duet evoC - distinguishes 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) revealing unprecedented insights into current and future states of disease using one 5ng DNA sample
DNA comprises molecular information stored in genetic and epigenetic bases, both of which are vital to our understanding of biology. The interplay between genetics and the DNA epigenome orchestrates complex biological phenomena as diverse as cell fate, ageing, the response to environmental stimuli, and disease pathogenesis.
Novel single-base-resolution solution that delivers the standard four-base sequencing (A, C, G, and T), and distinguishes between 5‑methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC), on the same DNA molecule.
duet multiomics solution +modC provides complete genetic and modified cytosine (modC) information from a single low volume DNA sample. Read the product sheet.
Explore the fascinating world of the different types of epigenetic modifications and the role of epigenetics in gene expression. Learn more.
Discover how DNA stores multimodal information through a process known as DNA methylation and its crucial role in gene expression and regulation.
Discover how new technology in next generation sequencing can capture the standard A, C, G, T bases plus epigenetic information in a single workflow.
In this Teach me in 10 episode we will explore how simultaneous sequencing of genetic and epigenetic bases in cfDNA allows for early cancer detection.
Enrichment protocols enable deep interrogation of target areas whilst maintaining cost effectiveness. Two enrichment methods performed with the duet multiomics solution +modC are presented here.
Join the Boston Epigenetics Society and biomodal founder Prof. Sir Shankar Balasubramanian FRS to discuss what DNA is trying to tell us.
Jointly brought to you by the UCLA Technical Center for Genomics & Bioinformatics (TCGB) and Jonsson Comprehensive Cancer Center (JCCC), and biomodal.
Uncover the role of DNA methylation in Alzheimer's disease research, from biomarker discovery to therapeutic potential.
Cambridge Epigenetix is now biomodal